SPRUCE BIOSCIENCES, INC. - Common Stock, par value $0.0001 per share (SPRB)

CUSIP: 85209E208

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 6 signals
Share change
-18,520
SEC-reported price per share
$65.35
Number of holders
32
Value change
-$3,009,590
Number of buys
13
Number of sells
14
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
2,775,534

Security key

85209E208

Report period

Q1 2026

Institutions

32

Top holders

10

Ownership snapshot

Top reported holders of SPRB - SPRUCE BIOSCIENCES, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Ikarian Capital, LLC
Disclosed value leader
Ikarian Capital, LLC
Comparable rows
15/15
Latest evidence
18 Feb 2026
13F 13D/G 3/4/5 Lead comparable stake: 11% 13D/G row: Ikarian Capital, LLC Showing 1-6 of 15 holder rows.

Quick read

Ikarian Capital, LLC leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Ikarian Capital, LLC's linked filing trail.
Comparable ownership Top 5
Ikarian Capital, LLC 11%
Boone Peter David Mr 6.4%
ADAR1 Capital Management, LLC 5.4%
CITADEL ADVISORS LLC 5.1%
Carlyle Group Inc. 4.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Ikarian Capital, LLC
13F 13D/G
Company
11%
from 13D/G
$10,571,320
121,356 shares
31 Dec 2025
Boone Peter David Mr
13D/G
6.4%
$8,045,712
68,184 shares
$0 21 Nov 2025
ADAR1 Capital Management, LLC
13F 13D/G
Company
5.4%
from 13D/G
$5,052,380
58,000 shares
31 Dec 2025
CITADEL ADVISORS LLC
13F 13D/G
Company · Kenneth Griffin
5.1%
from 13D/G
$6,097,613
69,999 shares
31 Dec 2025
Carlyle Group Inc.
13D/G 13F
The Carlyle Group Inc. · Company
4.7%
$4,208,342
50,893 shares
$0 18 Feb 2026
Alyeska Investment Group, L.P.
13F 13D/G
Company
4.5%
from 13D/G
$4,501,061
51,671 shares
31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
32
Shares
739,765
Rows available
32
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
32
Q1 2026 holders
32
Holder diff
0
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .